Literature DB >> 30213848

Three-Hour Delayed Imaging Improves Assessment of Coronary 18F-Sodium Fluoride PET.

Jacek Kwiecinski1,2, Daniel S Berman1, Sang-Eun Lee3, Damini Dey1, Sebastien Cadet1, Martin L Lassen1, Guido Germano1, Maurits A Jansen2, Marc R Dweck2, David E Newby2, Hyuk-Jae Chang3, Mijin Yun3, Piotr J Slomka4.   

Abstract

Coronary 18F-sodium fluoride (18F-NaF) PET identifies ruptured plaques in patients with recent myocardial infarction and localizes to atherosclerotic lesions with active calcification. Most studies to date have performed the PET acquisition 1 h after injection. Although qualitative and semiquantitative analysis is feasible with 1-h images, residual blood-pool activity often makes it difficult to discriminate plaques with 18F-NaF uptake from noise. We aimed to assess whether delayed PET performed 3 h after injection improves image quality and uptake measurements.
Methods: Twenty patients (67 ± 7 y old, 55% male) with stable coronary artery disease underwent coronary CT angiography (CTA) and PET/CT both 1 h and 3 h after the injection of 266.2 ± 13.3 MBq of 18F-NaF. We compared the visual pattern of coronary uptake, maximal background (blood pool) activity, noise, SUVmax, corrected SUVmax (cSUVmax), and target-to-background (TBR) ratio in lesions defined by CTA on 1-h versus 3-h 18F-NaF PET.
Results: On 1-h PET, 26 CTA lesions with 18F-NaF PET uptake were identified in 12 (60%) patients. On 3-h PET, we detected 18F-NaF PET uptake in 7 lesions that were not identified on 1-h PET. The median cSUVmax and TBRs of these lesions were 0.48 (interquartile range [IQR], 0.44-0.51) and 1.45 (IQR, 1.39-1.52), respectively, compared with -0.01 (IQR, -0.03-0.001) and 0.95 (IQR, 0.90-0.98), respectively, on 1-h PET (both P < 0.001). Across the entire cohort, 3-h PET SUVmax was similar to 1-h PET measurements (1.63 [IQR, 1.37-1.98] vs. 1.55 [IQR, 1.43-1.89], P = 0.30), and the background activity was lower (0.71 [IQR, 0.65-0.81] vs. 1.24 [IQR, 1.05-1.31], P < 0.001). On 3-h PET, TBR, cSUVmax, and noise were significantly higher (respectively: 2.30 [IQR, 1.70-2.68] vs. 1.28 [IQR, 0.98-1.56], P < 0.001; 0.38 [IQR, 0.27-0.70] vs. 0.90 [IQR, 0.64-1.17], P < 0.001; and 0.10 [IQR, 0.09-0.12] vs. 0.07 [IQR, 0.06-0.09], P = 0.02). Median cSUVmax and TBR increased by 92% (range, 33%-225%) and 80% (range, 20%-177%), respectively.
Conclusion: Blood-pool activity decreases on delayed imaging, facilitating the assessment of 18F-NaF uptake in coronary plaques. Median TBR increases by 80%, leading to the detection of more plaques with significant uptake than are detected using the standard 1-h protocol. A greater than 1-h delay may improve the detection of 18F-NaF uptake in coronary artery plaques.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-NaF; PET/CT; coronary artery disease; coronary artery imaging; delayed imaging

Mesh:

Substances:

Year:  2018        PMID: 30213848      PMCID: PMC6448466          DOI: 10.2967/jnumed.118.217885

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  32 in total

1.  Fluorine-18: a new isotope for bone scanning.

Authors:  M BLAU; W NAGLER; M A BENDER
Journal:  J Nucl Med       Date:  1962-07       Impact factor: 10.057

2.  Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque.

Authors:  Thorsten Derlin; Ulrich Richter; Peter Bannas; Philipp Begemann; Ralph Buchert; Janos Mester; Susanne Klutmann
Journal:  J Nucl Med       Date:  2010-05-19       Impact factor: 10.057

3.  Advantage of delayed whole-body FDG-PET imaging for tumour detection.

Authors:  K Kubota; M Itoh; K Ozaki; S Ono; M Tashiro; K Yamaguchi; T Akaizawa; K Yamada; H Fukuda
Journal:  Eur J Nucl Med       Date:  2001-06

4.  Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET.

Authors:  R A Hawkins; Y Choi; S C Huang; C K Hoh; M Dahlbom; C Schiepers; N Satyamurthy; J R Barrio; M E Phelps
Journal:  J Nucl Med       Date:  1992-05       Impact factor: 10.057

5.  Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Toshihide Monden; Yasuhiro Sasakawa; Kunihiko Tsutsui; Hisao Wakabayashi; Motoomi Ohkawa
Journal:  Nucl Med Commun       Date:  2005-10       Impact factor: 1.690

6.  Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma.

Authors:  Wan-Yu Lin; Shih-Chuan Tsai; Guang-Uei Hung
Journal:  Nucl Med Commun       Date:  2005-04       Impact factor: 1.690

7.  FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.

Authors:  Kazuo Kubota; Jyunkichi Yokoyama; Keiichiro Yamaguchi; Shuichi Ono; Ahmad Qureshy; Masatoshi Itoh; Hiroshi Fukuda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

Review 8.  Skeletal PET with 18F-fluoride: applying new technology to an old tracer.

Authors:  Frederick D Grant; Frederic H Fahey; Alan B Packard; Royal T Davis; Abass Alavi; S Ted Treves
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

9.  Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality.

Authors:  James K Min; Leslee J Shaw; Richard B Devereux; Peter M Okin; Jonathan W Weinsaft; Donald J Russo; Nicholas J Lippolis; Daniel S Berman; Tracy Q Callister
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

View more
  23 in total

1.  Selection of abstracts from the scientific sessions of The Society Of Nuclear Medicine and Molecular Imaging annual meeting Anaheim CA.

Authors:  Jacek Kwiecinski; Martin Lyngby Lassen; Joanna Liang; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2019-07-15       Impact factor: 5.952

2.  Hype or Hope18F-NaF Positron Emission Tomography for Vulnerable Coronary Plaque Imaging.

Authors:  Mani Salarian; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2019-08-06       Impact factor: 7.792

3.  Peri-Coronary Adipose Tissue Density Is Associated With 18F-Sodium Fluoride Coronary Uptake in Stable Patients With High-Risk Plaques.

Authors:  Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Sang-Eun Lee; Yuka Otaki; Phi T Huynh; Mhairi K Doris; Evann Eisenberg; Mijin Yun; Maurits A Jansen; Michelle C Williams; Balaji K Tamarappoo; John D Friedman; Marc R Dweck; David E Newby; Hyuk-Jae Chang; Piotr J Slomka; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2019-02-13

4.  Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography.

Authors:  Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Sang-Eun Lee; Balaji Tamarappoo; Yuka Otaki; Phi T Huynh; John D Friedman; Mark R Dweck; David E Newby; Mijin Yun; Hyuk-Jae Chang; Piotr J Slomka; Daniel S Berman
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-01-01       Impact factor: 6.875

Review 5.  Vulnerable plaque imaging using 18F-sodium fluoride positron emission tomography.

Authors:  Jacek Kwiecinski; Piotr J Slomka; Marc R Dweck; David E Newby; Daniel S Berman
Journal:  Br J Radiol       Date:  2019-12-19       Impact factor: 3.039

6.  Feasibility of Coronary 18F-Sodium Fluoride Positron-Emission Tomography Assessment With the Utilization of Previously Acquired Computed Tomography Angiography.

Authors:  Jacek Kwiecinski; Philip D Adamson; Martin L Lassen; Mhairi K Doris; Alastair J Moss; Sebastian Cadet; Maurits A Jansen; Damini Dey; Sang-Eun Lee; Mijin Yun; Hyuk-Jae Chang; Marc R Dweck; David E Newby; Daniel S Berman; Piotr J Slomka
Journal:  Circ Cardiovasc Imaging       Date:  2018-12       Impact factor: 7.792

7.  Coronary 18F-Sodium Fluoride Uptake Predicts Outcomes in Patients With Coronary Artery Disease.

Authors:  Jacek Kwiecinski; Evangelos Tzolos; Philip D Adamson; Sebastien Cadet; Alastair J Moss; Nikhil Joshi; Michelle C Williams; Edwin J R van Beek; Damini Dey; Daniel S Berman; David E Newby; Piotr J Slomka; Marc R Dweck
Journal:  J Am Coll Cardiol       Date:  2020-06-23       Impact factor: 24.094

8.  Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET.

Authors:  Martin Lyngby Lassen; Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Guido Germano; Daniel S Berman; Philip D Adamson; Alastair J Moss; Marc R Dweck; David E Newby; Piotr J Slomka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-05       Impact factor: 9.236

9.  Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden.

Authors:  Jacek Kwiecinski; Sebastien Cadet; Marwa Daghem; Martin L Lassen; Damini Dey; Marc R Dweck; Daniel S Berman; David E Newby; Piotr J Slomka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-02       Impact factor: 9.236

10.  Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity.

Authors:  Evangelos Tzolos; Jacek Kwiecinski; Martin Lyngby Lassen; Sebastien Cadet; Philip D Adamson; Alastair J Moss; Nikhil Joshi; Michelle C Williams; Edwin J R van Beek; Damini Dey; Daniel S Berman; Marc R Dweck; David E Newby; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2020-06-11       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.